Clinical Trials Browser

Phase 1 × Myelodysplastic Syndromes × N-desulfated,2-O,3-O-desulfated heparin × Clear all

NCT02995655 2019-12-05

CX-01 Combined With Azacitidine in the Treatment of Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia

Phase 1 Completed

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute